Literature DB >> 9101098

Serum uremic toxins from patients with chronic renal failure displace the binding of L-tryptophan to human serum albumin.

G Mingrone1, R De Smet, A V Greco, A Bertuzzi, A Gandolfi, S Ringoir, R Vanholder.   

Abstract

The level of free tryptophan (Trp) and its metabolites in serum appears to be related to some pathologic states, such as chronic renal failure and neuropsychiatric disorders, so that a precise characterization of tryptophan binding to serum albumin is of interest. In the present paper, the binding of L-tryptophan to defatted human serum albumin at 37 degrees C and at pH 7.4 was studied by means of equilibrium dialysis. The competition between L-tryptophan and serum solutes extracted from uremic patients undergoing hemodialysis, before dialysis treatment, was also investigated. Solutes were extracted from uremic pools of sera using two different deproteinization methods: serum ultrafiltration and heat denaturation of serum proteins followed by ultrafiltration. We found 1.10 +/- 0.03 binding sites for Trp to defatted albumin with an association constant 11.37 +/- 1.03 x 10(3) M-1. The competition experiments suggested that the number of Trp binding sites were not significantly modified by the addition of solutes obtained with the method of ultrafiltration with respect to the binding of L-tryptophan to albumin in the absence of competitors, while their affinity constant was markedly reduced (2.66 +/- 0.18 x 10(3) M-1). Moreover, a significant reduction of the affinity constant was observed when competitors for Trp were obtained using heat deproteinization associated with ultrafiltration (1.91 +/- 0.15 x 10(3) M-1 vs. 2.66 +/- 0.18 x 10(3) M-1; P < 0.005). These results might be ascribed to the fact that the last procedure has a higher yield with a more complete liberation of uremic toxins from serum proteins, so that they became probably totally free thus competing at higher extent with L-tryptophan for albumin binding sites.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9101098     DOI: 10.1016/s0009-8981(96)06504-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Prominent accumulation in hemodialysis patients of solutes normally cleared by tubular secretion.

Authors:  Tammy L Sirich; Benjamin A Funk; Natalie S Plummer; Thomas H Hostetter; Timothy W Meyer
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

2.  Elimination of endogenous toxin, creatinine from blood plasma depends on albumin conformation: site specific uremic toxicity & impaired drug binding.

Authors:  Ankita Varshney; Mohd Rehan; Naidu Subbarao; Gulam Rabbani; Rizwan Hasan Khan
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

3.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

4.  Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.

Authors:  Joosep Paats; Annika Adoberg; Jürgen Arund; Annemieke Dhondt; Anders Fernström; Ivo Fridolin; Griet Glorieux; Liisi Leis; Merike Luman; Emilio Gonzalez-Parra; Vanessa Maria Perez-Gomez; Kristjan Pilt; Didier Sanchez-Ospina; Mårten Segelmark; Fredrik Uhlin; Alberto Arduan Ortiz
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

5.  pH-Dependent Protein Binding Properties of Uremic Toxins In Vitro.

Authors:  Suguru Yamamoto; Kenichi Sasahara; Mio Domon; Keiichi Yamaguchi; Toru Ito; Shin Goto; Yuji Goto; Ichiei Narita
Journal:  Toxins (Basel)       Date:  2021-02-04       Impact factor: 4.546

6.  Untargeted plasma and tissue metabolomics in rats with chronic kidney disease given AST-120.

Authors:  Thomas J Velenosi; Anzel Hennop; David A Feere; Alvin Tieu; Andrew S Kucey; Polydoros Kyriacou; Laura E McCuaig; Stephanie E Nevison; Michael A Kerr; Bradley L Urquhart
Journal:  Sci Rep       Date:  2016-03-02       Impact factor: 4.379

7.  Drugs Commonly Applied to Kidney Patients May Compromise Renal Tubular Uremic Toxins Excretion.

Authors:  Silvia M Mihaila; João Faria; Maurice F J Stefens; Dimitrios Stamatialis; Marianne C Verhaar; Karin G F Gerritsen; Rosalinde Masereeuw
Journal:  Toxins (Basel)       Date:  2020-06-12       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.